- 2023 - 2028 Research and development of basic technology for sustainable medicinal plant production and production area formation
- 2022 - 2027 頚椎症性脊髄症の機能を軸索修復により根本的に回復する新しい植物性医薬品の開発
- 2023 - 2026 サルコペニアや生活不活発病による認知症発症を予防する抗ヘモペキシン戦略
- 2023 - 2025 プロテアソームによる異常タンパク質分解を活性化して健康寿命を伸ばす
- 2021 - 2024 高齢者疾患を制する和漢薬研究:製品化に向けた臨床研究と品質研究
- 2020 - 2022 Development of anti-Alzheimer's disease based on a ubiquitin-proteasome activator
- 2017 - 2022 Drug therapy of chronic phase of spinal cord injury; development of botanical drugs to improve muscle atrophy and axonal disruption
- 2018 - 2021 Development of therapeutic strategy for Alzheimer's disease via M2 microglia
- 2016 - 2019 Mode-of-action analysis of Kampo formulae and prediction of their new indications for a wide range of diseases
- 2015 - 2019 Search for marine natural products that act on "cellular machinery" on cell surface
- 2016 - 2018 神経回路網の再構築による認知症予防・改善のための機能性表示食品の開発
- 2015 - 2018 Study on medicinal plants in Asia for sustainable use of traditional medicines
- 2014 - 2017 Traditional medicine-based drug development-creation of new paradigm-
- 2013 - 2016 Design, Synthesis, and Structure-Activity Relationship Study of Novel Neuro-Protecting Drugs Based on Natural Product Hybridization
- 2012 - 2015 Construction of a program for sustainable use of traditional medicines, based on integrated study of genetic, chemical and pharmacological diversity of medicinal plants
- 2009 - 2014 Studies for the detail mechanisms of depression onset and the development of novel antidepressants based on "the Wakan-yaku, Sino-Japanese traditional medicine, theory"
- 2011 - 2014 富山県産和漢薬から開発する脊髄損傷改善薬に関する研究
- 2012 - 2013 アルツハイマー病を改善する新しい薬物とその分子機序
- 2011 - 2013 Recovery from spinal cord injury in the chronic phase -the mechanism of denosomin, a novel compound with multiactivities-
- 2009 - 2011 Analysis on genetic, chemical and pharmacological diversity of medicinal plants, towards sustainable uses of traditional medicines
- 2009 - 2011 Development of Novel Methodology for the Synthesis of 2, 3-Benzodiazepines and Application for Neuro-therapeutic Agents
- 2009 - 2010 新規薬物Denosominによる「むずむず脚症候群」原因遺伝子を介した脊髄損傷改善作用
- 2009 - 2010 伝統薬物研究から展開する神経創薬戦略-アルツハイマー病と脊髄損傷を克服する画期的な治療薬開発の実現に向かう研究-
- 2008 - 2010 Frontal lobe pathology in schizophrenia : its pathogenesis and the development of the drug
- 2007 - 2008 神経変性疾患に有効な伝統薬物分子の探索とその治療戦略
- 2005 - 2007 Identification of the intrinsic molecules which are involved in the generation of disease, and the analysis of the molecular mechanisms and functions, by using Wakan-yaku, Japanese traditional systematized medicine
- 2005 - 2007 Investigation on Kampo Drug Resources in Asia and Analysis on Diversity ofMedicinal Plants
- 2005 - 2007 Study of the molecular mechanism of synaptogenesis using withanolides, novel anti-dementia drugs
- 2005 - 2006 漢方処方を進化させる科学的アプローチ-痴呆を治療する処方の開発-
- 2005 - ADHD(注意欠陥多動性障害)の病態形成と脳内PI3 kinaseとの関連
- 2005 - Relation of PI3 kinase to ADHD etiology
- 2003 - 2004 漢方薬の作用機序を分子レベルで解明する新しいストラテジーの確立
- 2003 - 2004 薬物の作用機序を分子レベルで解明する新しい戦略 ~痴呆根治薬の解析への応用と、和漢薬研究におけるブレイクスルー
- 2002 - 2004 Inquiry into Kampo Drug Resources of Asia : Investigation on Mongolian and Thai Medicinal Plants
- 2002 - 2003 神経回路網再形成型の新しい抗痴呆薬~漢方方剤“続命湯”の作用~
- 2002 - 2003 mRNA動態の新概念~神経軸索を輸送されるmRNAの存在と神経回路網形成への関与
- 2001 - 2002 神経軸索終末に輸送されるmRNAのクローニング〜軸索形成に関与する因子の解析〜
- 2000 - 2001 「インド生薬Ashwagandha (Withania somnifera)中の神経回路網再生因子~作用機序の解明と抗痴呆薬への展開~」
- 1999 - 2001 Comparative Ethnopharmacology in China
- 1999 - 2000 新規因子sproutinの神経ネットワーク賦活化と痴呆の改善に及ぼす作用
- 1998 - 2000 MECHANISMS OF ALLERGIC ITCH
- 1997 - 1998 アトピー性皮膚炎の痒みに関連した因子の単離、同定および機能解析
- 1998 - 神経変性疾患(アルツハイマー病、脊髄損傷)を克服する治療薬の伝統薬物からの単離・同定、およびその作用機序解明による病態制分子の解析
- 1998 - Study of pathological mechanism of neurodegenerated diseases (Alzheimer's disease, spinal cord injury)and therapeutic strategy
- 神経可塑型性メカニズムに関する研究
- Study on a mechanism of neuronal plasticity
